Skip to Content

Kyowa Kirin Co Ltd KYKOF

Morningstar Rating
$20.29 +0.62 (3.14%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

KYKOF is trading at a 14% discount.
Price
$16.09
Fair Value
$97.53
Uncertainty
High
1-Star Price
$95.22
5-Star Price
$16.52
Economic Moat
Gnmcjcf
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if KYKOF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$19.67
Day Range
$20.2920.29
52-Week Range
$15.7822.67
Bid/Ask
$18.63 / $20.66
Market Cap
$10.91 Bil
Volume/Avg
100 / 2,397

Key Statistics

Price/Earnings (Normalized)
14.60
Price/Sales
2.84
Dividend Yield (Trailing)
2.36%
Dividend Yield (Forward)
2.45%
Total Yield
2.36%

Company Profile

Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Large Growth
Total Number of Employees
5,974

Comparables

Valuation

Metric
KYKOF
4516
4554
Price/Earnings (Normalized)
14.6012.998.51
Price/Book Value
1.581.491.02
Price/Sales
2.842.191.02
Price/Cash Flow
10.8512.934.40
Price/Earnings
KYKOF
4516
4554

Financial Strength

Metric
KYKOF
4516
4554
Quick Ratio
3.754.170.68
Current Ratio
4.385.921.46
Interest Coverage
229.64256.0255.27
Quick Ratio
KYKOF
4516
4554

Profitability

Metric
KYKOF
4516
4554
Return on Assets (Normalized)
8.07%9.57%3.39%
Return on Equity (Normalized)
9.93%11.30%7.02%
Return on Invested Capital (Normalized)
9.42%10.97%4.22%
Return on Assets
KYKOF
4516
4554
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - General Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
LLY
Eli Lilly and CoMpw$716.1 Bil
JNJ
Johnson & JohnsonZpcg$388.7 Bil
MRK
Merck & Co IncNznjz$322.0 Bil
ABBV
AbbVie IncJfgzj$311.0 Bil
RHHBY
Roche Holding AG ADRHtm$212.0 Bil
NVS
Novartis AG ADRNzfl$208.1 Bil
AZN
AstraZeneca PLC ADRSyky$195.9 Bil
PFE
Pfizer IncBbtw$150.0 Bil
AMGN
Amgen IncXpty$146.8 Bil
SNY
Sanofi SA ADRHxx$118.9 Bil

Sponsor Center